PEPE, ALESSIA
 Distribuzione geografica
Continente #
AS - Asia 8.236
NA - Nord America 7.247
EU - Europa 4.751
AF - Africa 2.705
SA - Sud America 2.548
OC - Oceania 256
Continente sconosciuto - Info sul continente non disponibili 135
Totale 25.878
Nazione #
US - Stati Uniti d'America 5.846
SG - Singapore 2.822
HK - Hong Kong 1.658
BR - Brasile 1.515
VN - Vietnam 640
PL - Polonia 554
CN - Cina 519
IT - Italia 469
FR - Francia 376
RU - Federazione Russa 278
FI - Finlandia 277
DE - Germania 227
AR - Argentina 195
AT - Austria 152
EC - Ecuador 142
TR - Turchia 126
ID - Indonesia 121
GB - Regno Unito 117
BJ - Benin 112
IE - Irlanda 110
IN - India 108
MX - Messico 105
RS - Serbia 104
CO - Colombia 103
ZA - Sudafrica 101
PY - Paraguay 99
UA - Ucraina 98
VE - Venezuela 98
MK - Macedonia 93
CR - Costa Rica 92
AE - Emirati Arabi Uniti 91
IQ - Iraq 90
MA - Marocco 90
LB - Libano 89
NL - Olanda 89
AO - Angola 88
BO - Bolivia 87
BY - Bielorussia 87
JO - Giordania 87
PT - Portogallo 87
PA - Panama 85
SE - Svezia 85
UZ - Uzbekistan 85
CL - Cile 83
PE - Perù 83
HN - Honduras 82
IR - Iran 82
KR - Corea 82
LC - Santa Lucia 82
LV - Lettonia 82
SA - Arabia Saudita 82
TH - Thailandia 82
TT - Trinidad e Tobago 82
GT - Guatemala 80
RO - Romania 80
AZ - Azerbaigian 79
HU - Ungheria 79
UG - Uganda 79
BE - Belgio 78
CI - Costa d'Avorio 78
DZ - Algeria 78
SN - Senegal 78
EE - Estonia 77
PH - Filippine 77
SI - Slovenia 77
MD - Moldavia 75
GR - Grecia 74
JM - Giamaica 74
KZ - Kazakistan 74
NO - Norvegia 74
TN - Tunisia 74
ZM - Zambia 74
BB - Barbados 73
EG - Egitto 73
GA - Gabon 73
TJ - Tagikistan 73
UY - Uruguay 73
KE - Kenya 72
MZ - Mozambico 72
YE - Yemen 72
HR - Croazia 71
LY - Libia 71
MN - Mongolia 71
NI - Nicaragua 71
GF - Guiana Francese 70
BF - Burkina Faso 69
BZ - Belize 69
CW - ???statistics.table.value.countryCode.CW??? 69
CD - Congo 68
CY - Cipro 68
DK - Danimarca 68
IS - Islanda 68
ME - Montenegro 68
PK - Pakistan 68
BW - Botswana 67
HT - Haiti 67
IL - Israele 67
LU - Lussemburgo 67
MR - Mauritania 67
MU - Mauritius 67
Totale 22.630
Città #
Hong Kong 1.603
Singapore 1.080
Fairfield 732
Bytom 473
Ashburn 464
Boardman 400
Medford 355
Princeton 354
Des Moines 272
Ho Chi Minh City 250
Houston 239
San Diego 218
Cambridge 216
Santa Clara 212
Helsinki 203
Beijing 186
Chicago 164
Wilmington 149
São Paulo 131
Chandler 129
Los Angeles 129
Hanoi 127
Woodbridge 106
Cotonou 102
Seattle 93
Dublin 91
Vienna 87
Amman 81
Padova 80
Castries 79
Dakar 78
Luanda 78
Kampala 77
Panama City 77
Baku 76
Abidjan 74
San José 74
Buffalo 72
Lusaka 72
Tashkent 72
Managua 69
Dushanbe 68
Libreville 68
Ulan Bator 68
Riga 66
Bridgetown 65
Andorra la Vella 63
Ann Arbor 63
Conakry 62
Nouakchott 62
Minsk 61
Salt Lake City 61
Montevideo 58
Nairobi 58
Podgorica 58
Willemstad 58
Tallinn 57
Antananarivo 55
Lima 55
Phnom Penh 55
Accra 54
Maputo 54
New York 54
Bishkek 52
Kigali 52
Kinshasa 52
Vientiane 52
Guatemala City 50
Niamey 50
Nuremberg 50
Ouagadougou 50
Sanaa 50
Bamako 49
Reykjavik 49
Dili 48
Praia 48
Tripoli 48
Yerevan 48
Guayaquil 47
Noumea 47
Tbilisi 47
Addis Ababa 46
Belgrade 46
Chisinau 46
Gaborone 46
Kingston 46
Nassau 46
Cayenne 45
Kingstown 45
Pristina 45
Skopje 45
Havana 44
Rio de Janeiro 44
Djibouti 43
Ljubljana 43
Munich 43
Zagreb 43
Quito 42
Lilongwe 41
Dar es Salaam 40
Totale 12.675
Nome #
Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update 227
Early Detection of Myocardial Involvement in Thalassemia Intermedia Patients: Multiparametric Mapping by Magnetic Resonance Imaging 198
Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor study 185
Left and right ventricular morphology, function and late gadolinium enhancement extent and localization change with different clinical presentation of acute myocarditis Data from the Italian multicenter study on MYocarditis (ITAMY) 166
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 159
Could CT Radiomic Analysis of Benign Adrenal Incidentalomas Suggest the Need for Further Endocrinological Evaluation? 150
Medical Radiology: Current Progress. 146
Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review 146
Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method 145
Overcoming the Boundaries of Heart Warm Ischemia in Donation After Circulatory Death: The Padua Case 138
Clinical Value and Prognostic Impact of Pericardial Involvement in Acute Myocarditis Data From the ITAMY 135
Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy 128
Ischemic Heart DiseaseFrom Diagnosis to Treatment 125
Atrial dimension reference values in healthy participants using the biplane/monoplane method for clinical and research use 114
Standards for conducting and reporting consensus and recommendation documents: European Society of Cardiovascular Radiology policy from the Guidelines Committee 111
Multimodality Imaging in Restrictive Cardiomyopathies. An EACVI expert consensus document. In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology. Endorsed by the Indian Academy of echocardiography 108
CMR for myocardial iron overload quantification: calibration curve from the MIOT Network 108
Tumor Diagnosis and Treatment: Imaging Assessment 107
A complication risk score to evaluate clinical severity of thalassaemia syndromes 107
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 106
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 106
Additional value of segmental parametric mapping by Cardiovascular Magnetic Resonance in competitive athletes 105
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 105
Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism 103
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Cardiovascular magnetic resonance and nuclear cardiology 103
Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment 102
Advantages of Photon-Counting Detector CT in Aortic Imaging 102
Absence of long-term incremental prognostic value of inducible wall motion abnormalities on dipyridamole stress CMR in patients with suspected or known coronary artery disease 102
Textbook outcome and nomogram-guided approaches for enhancing surgical success in elderly HCC patients: Deciphering the influence of sarcopenia 101
Clinical recommendations of cardiac magnetic resonance, Part I: ischemic and valvular heart disease: a position paper of the working group ‘Applicazioni della Risonanza Magnetica’ of the Italian Society of Cardiology 100
Potential Benefits of Photon-Counting CT in Dental Imaging: A Narrative Review 98
Clinical recommendations of cardiac magnetic resonance, Part II: inflammatory and congenital heart disease, cardiomyopathies and cardiac tumors: a position paper of the working group ‘Applicazioni della Risonanza Magnetica’ of the Italian Society of Cardiology 98
Effect of inversion-recovery fat suppression on hepatic R2* quantitation in transfusional siderosis 96
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology. 94
Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a “Protective” Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients? 94
The additive prognostic value of end-systolic pressure-volume relation by stress CMR in patients with known or suspected coronary artery disease 93
Take a look at the heart: Incidental detection of a right atrial thrombus during abdominal MR 93
Feasibility, reproducibility, and reliability for the T2* iron evaluation at 3 T in comparison with 1.5 T 93
The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular trabeculation 93
The link of pancreatic iron with glucose metabolism and cardiac iron in thalassemia intermedia: A large, multicenter observational study 93
Arterial hypertension in the female world: pathophysiology and therapy 91
Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications 91
Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment 90
Left ventricle remodeling in patients with β-thalassemia major. An emerging differential diagnosis with left ventricle noncompaction disease 89
Combined Brain-Heart Imaging in Takotsubo Syndrome: Towards a Holistic Patient Assessment 88
Improving the Preclinical Models for the Study of Chemotherapy-Induced Cardiotoxicity. A Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 88
9) Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective 88
27) Different patterns of myocardial iron distribution by whole-heart T2* Magnetic Resonance as risk markers for heart complications in thalassemia major. 88
National networking in rare diseases and reduction of cardiac burden in thalassemia major 88
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview 87
Myocardial T1 Values at 1.5 T: Normal Values for General Electric Scanners and Sex-Related Differences 87
Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study 85
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients 85
Cardiac R2* values are independent of the image analysis approach employed 85
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia 85
Non-compact myocardium assessment by cardiac magnetic resonance: dependence on image analysis method. 84
Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition? 84
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 84
Cardiovascular Magnetic Resonance Reveals Cardiac Inflammation and Fibrosis in Symptomatic Patients with Post-COVID-19 Syndrome: Findings from the INSPIRE-CMR Multicenter Study 83
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients 83
Setting for “normal” serum ferritin levels in patients with transfusion‐dependent thalassemia: Our current strategy 83
The close link of pancreatic iron with glucose metabolism and with cardiac complications in thalassemia major: A large, multicenter observational study 83
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study 83
Combined brain-heart MRI identifies cardiac and white matter lesions in patients with systemic lupus erythematosus and/or antiphospholipid syndrome: A pilot study 82
Pathophysiology of anthracycline cardiotoxicity. 82
Myocardial T2 values at 1.5 T by a segmental approach with healthy aging and gender 82
MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine 82
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience 82
Robust estimation of pulse wave transit time using group delay 80
36) The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages 80
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach 80
Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron 80
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 80
A robust method for assessment of iron overload in liver by magnetic resonance imaging. 80
4) The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients 79
The planimetric Grothoff's criteria by cardiac magnetic resonance can improve the specificity of left ventricular non-compaction diagnosis in thalassemia intermedia 79
Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial 79
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network 79
Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia 78
Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up. 78
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial 78
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 78
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 77
Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron 77
Correction: Standards for conducting and reporting consensus and recommendation documents: European Society of Cardiovascular Radiology policy from the Guidelines Committee 76
Assessment of atrial diastolic function in patients with hypertrophic cardiomyopathy by cine magnetic resonance imaging 76
Pulmonary hypertension in well-transfused thalassemia major patients 76
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients 76
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 76
Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) 76
Multi-Modality Imaging in Cardio-Rheumatology 75
Oxidative Stress and Antioxidant Status in Adult Patients with Transfusion-Dependent Thalassemia: Correlation with Demographic, Laboratory, and Clinical Biomarkers 75
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 75
Liver T1 and T2 mapping in a large cohort of healthy subjects: normal ranges and correlation with age and sex 75
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia 75
Improved T2* assessment in liver iron overload by magnetic resonance imaging 75
Quantitative T2* magnetic resonance imaging for renal iron overload assessment: normal values by age and sex 75
Non-compact myocardium assessment by cardiac magnetic resonance: dependence on image analysis method 75
Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance 75
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: The Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 75
Totale 9.643
Categoria #
all - tutte 93.336
article - articoli 75.129
book - libri 346
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.594
Totale 170.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 1 2 9 8 10 9 19
2021/20222.809 0 4 20 8 949 67 61 224 616 29 106 725
2022/2023975 604 17 5 24 55 83 0 37 52 28 59 11
2023/2024873 16 56 52 41 61 50 49 56 44 15 254 179
2024/20256.370 30 301 445 60 593 109 257 521 865 364 1.145 1.680
2025/202615.043 664 2.410 4.549 4.641 2.310 469 0 0 0 0 0 0
Totale 26.346